Paired pre- and post-transplant human immunoprofiling identifies an IFN-γ-JAK1 axis limiting stem-cell-derived RPE engraftment
Cell Stem Cell · 2026
DOI: 10.1016/j.stem.2026.05.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Stem Cell, 2026. Verfasst von Junfeng Ma und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stem Cell Technology, First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China; Translational Medicine Research…. Hauptthemen laut MEDLINE: Retinal Pigment Epithelium, Janus Kinase 1, Interferon-gamma, Human Embryonic Stem Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Shanxi Provincial Key Research and Development Project, Shanxi Provincial Education Department, National Key Research and Development Program of China Stem Cell and Translational Research.
Abstract (Originalsprache)
Neovascular age-related macular degeneration is a major cause of irreversible blindness, and current therapies do not restore photoreceptors or retinal pigment epithelium (RPE). Human embryonic stem-cell-derived RPE (hESC-RPE) transplantation represents a potential regenerative strategy, but immune rejection limits durable engraftment. Here, we combine immune profiling of blood, aqueous humor, and retinal tissue with allogeneic co-cultures and humanized models to define determinants of graft vulnerability and assess a graft-directed intervention. We identify a Th1-skewed, IFN-γ-rich immune milieu across the circulation and eye and show that IFN-γ-JAK1 signaling promotes an immunogenic state in hESC-RPE, marked by increased HLA expression and antigen presentation features. Brief ex vivo conditioning with ruxolitinib attenuates this response while preserving epithelial properties. In humanized retinal degeneration models, conditioned grafts show reduced T/natural killer (NK)-cell infiltration, prolonged survival, and improved visual function without chronic systemic immunosuppression, supporting ex vivo JAK inhibition as a feasible adjunct to RPE cell therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stem Cell Technology, First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China; Translational Medicine Research Center, Shanxi Medical University, Taiyuan 030001, China.
- Department of Stem Cell Technology, First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China; Southwest Hospital, Army Medical University, Key Lab of Visual Damage and Regeneration and Restoratio…
- Southwest Hospital, Army Medical University, Key Lab of Visual Damage and Regeneration and Restoration of Chongqing, Chongqing 400038, China.
- Ophthalmology Medical Center, First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, China.
- Key Laboratory of Reproductive Medicine and Offspring Health, Clinical Center for Reproductive Medicine, First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.
- Department of Pharmacology, College of Pharmacy, Army Medical University, Chongqing 400038, China.
Förderung
- Shanxi Provincial Key Research and Development Project
- Shanxi Provincial Education Department
- National Key Research and Development Program of China Stem Cell and Translational Research
- Natural Science Foundation Project of Chongqing
- Key Research and Development Projects of Shaanxi Province
- Shanxi Scholarship Council of China
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Ma, J., Zhu, L., Duan, P., Ding, T., Cheng, Z., Li, B., Wang, Q., Ma, X., Deng, Y., Lamba, D. A., & Gao, Y. (2026). Paired pre- and post-transplant human immunoprofiling identifies an IFN-γ-JAK1 axis limiting stem-cell-derived RPE engraftment. Cell Stem Cell. https://doi.org/10.1016/j.stem.2026.05.006
Vancouver
Ma J, Zhu L, Duan P, Ding T, Cheng Z, Li B, et al. Paired pre- and post-transplant human immunoprofiling identifies an IFN-γ-JAK1 axis limiting stem-cell-derived RPE engraftment. Cell Stem Cell. 2026. doi:10.1016/j.stem.2026.05.006
BibTeX
@article{Ma2026,
author = {Ma, Junfeng and Zhu, Lifu and Duan, Ping and Ding, Tao and Cheng, Zhenghang and Li, Bin and Wang, Qingfeng and Ma, Xiang and Deng, Youcai and Lamba, Deepak A and Gao, Yuan},
title = {Paired pre- and post-transplant human immunoprofiling identifies an IFN-γ-JAK1 axis limiting stem-cell-derived RPE engraftment},
journal = {Cell Stem Cell},
year = {2026},
doi = {10.1016/j.stem.2026.05.006}
}
EUVIMED